Skip to content
WideVault offers secure digital storage solutions, data pro…

Giving Pluripotent Cells During Pregnancy to Infants with Spina Bifida Boosts Life Outcomes, Research Shows

A pioneering medical trial has found that administering stem cells to fetuses diagnosed with spina bifida during corrective surgery can be a "important advancement" in treating birth defects.

Trial Details and Safety

The research conducted in the United States involved six unborn babies with the 'open' form of spina bifida. Surgeons applied placenta-derived mesenchymal stem cells to the surface of the baby's spinal cord as part of the surgical correction.

Importantly, the cell therapy proved to be secure. The study team reported that the treatment did not lead to cancerous growths, disrupt the healing process, or impede the resolution of related neurological issues.

Promising Outcomes

Imaging conducted after delivery confirmed a successful correction of Chiari malformation in each of the babies. This favorable anatomical change is strongly associated with better mobility and function.

"Should it enable a greater number of infants able to walk who previously could not, then it would become the conventional approach," noted the study director. "The results are extremely promising and open the door to lots of potential new treatments."

Future Implications and Hope

Independent medical specialists have suggested that further confirmation of these apparent benefits could herald a "different age" in prenatal intervention. The possibility of ameliorating nerve function impairment seen in utero is considered a transformative goal.

Especially significant would be improvements in continence and digestive health, which are frequent complications for those diagnosed with this defect.

The Path Forward

Despite this being a first-in-human effort was small in scale, its safety demonstration and positive signals offer a robust platform for larger, more comprehensive studies. The integration of stem cell therapy with proven prenatal surgical methods presents significant potential for transforming outcomes for babies yet to be born with myelomeningocele.

The writer

Robert Spencer

Cybersecurity specialist with over a decade of experience in data protection and digital forensics, passionate about educating users on online safety.

WideVault

Type to search articles.